| Initial public offering of up to 37,71,600 equity shares of Rs.10/- each ("Equity Shares") of Bio Medica Laboratories Limited ("Bio Medica" or "BMLL" or the "Company" or the "Issuer) for cash at a price of Rs. [*]/- per equity share (the "Issue Price"), aggregating to Rs. [*] crores ("the Issue") comprising a fresh issue of up to 33,94,800 equity shares aggregating to Rs. [*] crores by the company ("Fresh Issue") and an offer for sale of up to 1,88,400 equity shares by Mukesh Mehta and up to 1,88,400 equity shares by Pradeep Mehta ("the Promoter" or "the Selling Shareholder") aggregating to Rs. [*] crores ("Offer for Sale"). Out of the issue, 1,89,600 equity shares aggregating to Rs. [*] crores will be reserved for subscription by market maker ("Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. issue of 35,82,000 equity shares of face value of Rs. 10/- each at an issue price of Rs. [*]/- per equity share aggregating to Rs. [*] crores is hereinafter referred to as the "Net Issue". The issue and the net issue will constitute 29.99% and 28.49%, respectively of the post issue paid up equity share capital of the company.
The face value of the equity shares is Rs.10/- each and the floor price and cap price are [*] times and [*] times of the face value of the equity shares, respectively. |
